Canada markets closed

Aligos Therapeutics, Inc. (ALGS)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.7303-0.0462 (-5.95%)
At close: 04:00PM EDT
0.7500 +0.02 (+2.70%)
After hours: 05:16PM EDT
Show:
Income Statement
Cash Flow
Annual

Balance Sheet

All numbers in thousands
Breakdown
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Assets
Current Assets
Cash
Cash And Cash Equivalents
135,704
81,347
186,816
220,383
Other Short Term Investments
0
44,480
3,918
23,130
Total Cash
135,704
125,827
190,734
243,513
Other Current Assets
5,310
7,603
13,526
5,944
Total Current Assets
141,084
133,545
204,424
250,017
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
20,573
22,082
22,231
19,151
Accumulated Depreciation
-10,755
-9,568
-7,262
-4,243
Net property, plant and equipment
9,818
12,514
14,969
14,908
Equity and other investments
-
0
15,110
0
Other long-term assets
625
634
866
377
Total non-current assets
10,443
13,148
30,945
15,285
Total Assets
151,527
146,693
235,369
265,302
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Accounts Payable
2,517
4,737
3,015
3,313
Accrued liabilities
3,025
1,473
1,235
167
Deferred revenues
1,308
9,210
7,641
7,891
Other Current Liabilities
-
66
276
569
Total Current Liabilities
23,906
33,129
38,957
30,274
Non-current liabilities
Deferred revenues
0
233
0
4,109
Other long-term liabilities
46
-
133
379
Total non-current liabilities
35,541
9,664
11,681
14,989
Total Liabilities
59,447
42,793
50,638
45,263
Stockholders' Equity
Common Stock
7
4
4
4
Retained Earnings
-486,797
-399,118
-303,072
-174,740
Accumulated other comprehensive income
545
401
452
-188
Total stockholders' equity
92,080
103,900
184,731
220,039
Total liabilities and stockholders' equity
151,527
146,693
235,369
265,302